(lp0
S'Why Anacor Pharmaceuticals, Inc. Stock Jumped 58.3% in May Motley Fool - Jun 5, 2016 What: Shares of Anacor Pharmaceuticals, Inc. , a biopharmaceutical company discovering, developing, and commercializing novel small-molecule therapeutics, shot up 58.3% last month, according to data from S&amp;P Global Market&nbsp;...'
p1
aS"Apple Inc. and Anacor Pharmaceuticals Inc. Soar As Stocks Jump Motley Fool - May 16, 2016 Pfizer made the purchase mainly to get its hands on Anacor's cisaborole, which is a topical treatment for eczema that's currently under review by the FDA."
p2
aS"Why Anacor Pharmaceuticals, Inc.'s Stock Skyrocketed Today Motley Fool - Jul 13, 2015 What: Shares of Anacor Pharmaceuticals  rose by over 40% today on heavy volume after the company released positive top-line results from two pivotal late-stage trials for crisaborole topical ointment as a treatment for mild-to-moderate&nbsp;...Wedbush On Anacor Pharma: Crisaborole Delivers, Reiterate Outperform - BenzingaAnacor Pharmaceuticals Inc  May Have A Home Run Drug On Its Hands - Smarter Analyst"
p3
aS"Pfizer's Buyout of Anacor Pharmaceuticals for $5.2 Billion Is a Bad Move ... Motley Fool - May 24, 2016 On May 16, Pfizer announced that it was acquiring Anacor Pharmaceuticals  for the hefty sum of $99.25 in cash per share, or a 55% premium to where Anacor shares closed on Friday. The crown jewel of the $5.2 billion acquisition is&nbsp;..."
p4
aS'Why Anacor Pharmaceuticals, Inc. Shot Higher Motley Fool - Mar 13, 2015 What: Shares in Anacor Pharmaceuticals  jumped by more than 15% today after reporting fourth quarter sales and earnings that eclipsed Wall Street forecasts.'
p5
aS"Anacor Pharmaceuticals Is Too Expensive Seeking Alpha - Jan 19, 2016 Sandoz is responsible for Kerydin's commercialization and Anacor is entitled to 50% of gross profit  and the company received $20 million in Q3 as Sandoz generated $40 million in sales. This represents an annual run rate ..."
p6
aS"Anacor Pharmaceuticals: The Devil You Don't Know Seeking Alpha - Jul 17, 2015 Anacor  is working toward bringing its boron-based topical anti-inflammatory phosphodiesterase 4 inhibitor  to the market."
p7
aS'Anacor Looks Much Better Now Seeking Alpha - Apr 7, 2016 The stock is down 30% since the call was made, and the company has raised capital through a convertible note offering, removing the financing overhang.'
p8
aS"With 365% stock climb, this Bay Area drug maker has skin in the game San Francisco Business Times  - Jul 31, 2015 Wall Street is scratching its health care itch, nearly quadrupling the value of Anacor Pharmaceuticals Inc.'s stock on the hopes of quick regulatory approval and a potential 2017 launch of the company's late-stage eczema treatment."
p9
aS"Anacor Pharmaceuticals Announces FDA Acceptance of NDA for Crisaborole Topical ... Business Wire  - Mar 22, 2016 PALO ALTO, Calif.----Anacor Pharmaceuticals, Inc.  announced today that the U.S. Food and Drug Administration  has accepted for review Anacor's New Drug Application  seeking approval of crisaborole&nbsp;...Anacor Pharma's  Crisaborole NDA as Atopic Dermatitis Treatment Accepted ... - StreetInsider.com"
p10
a.